Analyst Ratings For Acadia Healthcare Company Inc (NASDAQ:ACHC)
Today, Acadia Healthcare Company Inc (NASDAQ:ACHC) stock was downgraded by BMO Capital Markets from Outperform to Market Perform with a price target of $45.00.
There are 8 Buy Ratings, 5 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Acadia Healthcare Company Inc (NASDAQ:ACHC) is Buy with a consensus target price of $44.00 per share, a potential 6.90% upside.
Some recent analyst ratings include
- 8/1/2018-BMO Capital Markets was Downgraded by analysts at BMO Capital Markets from a “Outperform ” rating to a ” Market Perform” rating. They now have a $45.00 price target on the stock.
- 2/27/2018-Royal Bank of Canada Reiterated Rating of Buy.
- 2/25/2018-Cantor Fitzgerald Upgrade from a “Neutral ” rating to a ” Overweight” rating.
- 1/30/2018-Wells Fargo & Co initiated coverage with a Outperform rating.
- On 7/26/2018 Reeve B Waud, Director, sold 8,135 with an average share price of $45.00 per share and the total transaction amounting to $366,075.00.
- On 3/15/2018 Reeve B Waud, Director, sold 7,698 with an average share price of $42.03 per share and the total transaction amounting to $323,546.94.
- On 3/14/2018 Randall P Goldberg, VP, sold 400 with an average share price of $41.47 per share and the total transaction amounting to $16,588.00.
- On 3/13/2018 Reeve B Waud, Director, sold 42,302 with an average share price of $42.02 per share and the total transaction amounting to $1,777,530.04.
- On 3/6/2018 Reeve B Waud, Director, sold 200,000 with an average share price of $39.02 per share and the total transaction amounting to $7,804,000.00.
- On 3/2/2018 Reeve B Waud, Director, sold 150,000 with an average share price of $38.67 per share and the total transaction amounting to $5,800,500.00.
- On 3/1/2018 Randall P Goldberg, VP, sold 960 with an average share price of $38.47 per share and the total transaction amounting to $36,931.20.
About Acadia Healthcare Company Inc (NASDAQ:ACHC)
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It also provides outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder. In addition, the company provides mental health services; rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and long-term and non-acute care services for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides education and children's services for children and young people with special educational needs; adult and elderly care services; and care first services for employees. As of December 31, 2017, the company operated a network of 582 behavioral healthcare facilities with approximately 17,800 beds in the United States, the United Kingdom, and Puerto Rico. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Recent Trading Activity for Acadia Healthcare Company Inc (NASDAQ:ACHC)
Shares of Acadia Healthcare Company Inc closed the previous trading session at 41,04 up +1,56 3,96 % with 41.38 shares trading hands.